GL1X · GenesisL1 explorer

MolNFT v1 · #80354 · protein

Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl- N-((1-carbamimidoyl-4-PIPERIDINYL)METHYL)-L-prolinamide (bms-189664)

3TU7 · Prothrombin: “Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl…”. X-ray diffraction, 1 ligand (0BM), 3 pockets (best druggability 0.58). MolNFT v1 #80354 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3TU7
Type
protein
Length
292 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Prothrombin; Hirudin variant-2
EC
3.4.21.5
UniProt
P00734, P09945
Ligands
0BM
Pockets
3 · best druggability 0.58

Structure

x-ray diffraction · 3 distinct chains · 17% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LProthrombin (EC 3.4.21.5)protein3132% helix, 0% strandP00734
HProthrombin (EC 3.4.21.5)protein25015% helix, 35% strandP00734
IHirudin variant-2protein1127% helix, 0% strandP09945

Ligands and binding sites

  • 0BM · N-(methylsulfonyl)-D-phenylalanyl-N-[(1-carbamimidoylpiperidin-4-yl)methyl]-L-prolinamide · ligand · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12310.580.79400BM
2570.490.8617empty
3580.340.7719empty

Interfaces

2 interfaces between chains.

  • L–H · 1297 Ų buried · 27 hydrogen bonds · protein-protein
  • H–I · 657 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, phosphorylation).

Compared structures

  • 3TU7 · Human alpha-thrombin complexed with N-(methylsulfonyl)-D-phenylalanyl-N-((1-carbamimidoyl… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.